» Authors » Thora Wesenberg Helt

Thora Wesenberg Helt

Explore the profile of Thora Wesenberg Helt including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 6
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kempf O, Helt T, Herrche-Petersen J, Sondergaard C, Longin E, Ellerman A, et al.
Acta Paediatr . 2025 Feb; PMID: 39968885
Aim: This study examines trends in paracetamol overdoses among Danish adolescents during and following the COVID-19 pandemic. Methods: A retrospective observational study was conducted using data from the national databases,...
2.
Holm-Weber T, Mohanakumar S, Helt T, Borgwardt L, Borgwardt L, Juul K, et al.
Cardiol Young . 2024 Oct; 34(10):2105-2111. PMID: 39387246
Introduction: Tetralogy of Fallot patients face an elevated risk of developing chylothorax and pleural effusions post-surgery. This patient group exhibits risk factors known to compromise the lymphatic system, such as...
3.
Helt T, Christensen J, Berg R, Lund T, Kalhauge A, Ronsholt F, et al.
Physiol Rep . 2024 Sep; 12(17):e16184. PMID: 39245803
After COVID-19 long term respiratory symptoms and reduced lung function including maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP) have been reported. However, no studies have looked at MIP...
4.
Kempf O, Helt T, Johansen K, Rittig C, Lundby-Christensen L, Frederiksen M, et al.
Dan Med J . 2024 May; 71(5). PMID: 38704838
Introduction: To assess the effect of long-term isolation on the mental state of Danish youth. This study aimed to investigate trends in paracetamol overdoses among people under 18 years of...
5.
Lytzen A, Helt T, Christensen J, Lund T, Kalhauge A, Ronsholt F, et al.
Exp Physiol . 2024 Mar; 109(5):652-661. PMID: 38532277
Many patients exhibit persistently reduced pulmonary diffusing capacity after coronavirus disease 2019 (COVID-19). In this study, dual test gas diffusing capacity for carbon monoxide and nitric oxide (D) metrics and...
6.
Helt T, Johansen L, Faurholt-Jepsen D, Larsen V, Borgwardt L, Mortensen J, et al.
Acta Paediatr . 2024 Feb; 113(6):1168-1185. PMID: 38406880
Aim: To determine if children with neonatal cholestatic liver disease had concurrent and later findings on brain imaging studies that could be attributed and the cholestasis to contribute to the...
7.
Hansen K, Kjaergaard J, Kvistgaard H, Grosen D, Holm M, Gerstoft J, et al.
Ugeskr Laeger . 2024 Jan; 186(1). PMID: 38235776
The primary purpose of treating chronic hepatitis C (HCV) is to prevent the development of liver fibrosis, cirrhosis, and cancer. In the last decade, direct-acting antiviral medicine (DAA) has been...
8.
Winther C, Nyrann S, Nielsen R, Duno M, Johansen K, Helt T, et al.
Acta Paediatr . 2023 Nov; 113(3):580-589. PMID: 38009616
Aim: The longitudinal health status of Danish children with alpha-1 antitrypsin deficiency had never previously been characterised. This study aimed to assess the changes in growth, lung and liver function...
9.
Helt T, Buelund L, Borgwardt L, Eriksen T, Johansen L, de Nijs R, et al.
Biochem Biophys Rep . 2023 Jun; 34:101487. PMID: 37265596
Biliary atresia (BA) is a rare congenital liver disease with unknown etiology, and it is the most common indication for liver transplantation in children. As BA infants suffer from intestinal...
10.
Katzenstein T, Christensen J, Lund T, Kalhauge A, Ronsholt F, Podlekareva D, et al.
J Clin Med . 2022 Oct; 11(19). PMID: 36233555
A large proportion of patients exhibit persistently reduced pulmonary diffusion capacity after COVID-19. It is unknown whether this is due to a post-COVID restrictive lung disease and/or pulmonary vascular disease....